You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Title |
Rivastigmine: an open-label, observational study of safety and effectiveness in treating patients with Alzheimer's disease for up to 5 years
|
---|---|
Published in |
BMC Geriatrics, January 2005
|
DOI | 10.1186/1471-2318-5-3 |
Pubmed ID | |
Authors |
Martin R Farlow, Mary L Lilly, for the ENA713 B352 Study Group |
Mendeley readers
The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Brazil | 2 | 4% |
United States | 2 | 4% |
United Kingdom | 1 | 2% |
Unknown | 43 | 90% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 9 | 19% |
Student > Postgraduate | 5 | 10% |
Professor > Associate Professor | 5 | 10% |
Researcher | 4 | 8% |
Student > Ph. D. Student | 3 | 6% |
Other | 8 | 17% |
Unknown | 14 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 14 | 29% |
Psychology | 3 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 6% |
Chemistry | 2 | 4% |
Neuroscience | 2 | 4% |
Other | 5 | 10% |
Unknown | 19 | 40% |